These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9501967)

  • 1. Targeting of peptide and protein drugs to specific sites in the oral route.
    Bai JP; Chang LL; Guo JH
    Crit Rev Ther Drug Carrier Syst; 1995; 12(4):339-71. PubMed ID: 9501967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.
    Bai JP; Amidon GL
    Pharm Res; 1992 Aug; 9(8):969-78. PubMed ID: 1409387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral colon delivery of insulin with the aid of functional adjuvants.
    Maroni A; Zema L; Del Curto MD; Foppoli A; Gazzaniga A
    Adv Drug Deliv Rev; 2012 May; 64(6):540-56. PubMed ID: 22086142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbially triggered drug delivery to the colon.
    Sinha VR; Kumria R
    Eur J Pharm Sci; 2003 Jan; 18(1):3-18. PubMed ID: 12554067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral colon-specific drug delivery of protein and peptide drugs.
    Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
    Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azo chemistry and its potential for colonic delivery.
    Jain A; Gupta Y; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2006; 23(5):349-400. PubMed ID: 17425512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
    Yamamoto A; Ukai H; Morishita M; Katsumi H
    Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeation enhancers for oral peptide delivery.
    Maher S; Mrsny RJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches and opportunities in colon-specific drug delivery.
    Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):101-49. PubMed ID: 9501968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The colon as a possible target for orally administered peptide and protein drugs.
    Haupt S; Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 2002; 19(6):499-551. PubMed ID: 12822734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of site-dependent degradation of peptide drugs within the gut of rats and rabbits.
    Bai JP; Chang LL
    J Pharm Pharmacol; 1993 Dec; 45(12):1085-7. PubMed ID: 7908979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of regional differences in activities of brush-border membrane peptidases within the rat intestine on site-dependent stability of peptide drugs.
    Bai JP
    Life Sci; 1993; 53(15):1193-201. PubMed ID: 8412476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): the rational use of ex vivo intestine to predict in vivo absorption.
    Collett A; Stephens RH; Harwood MD; Humphrey M; Dallman L; Bennett J; Davis J; Carlson GL; Warhurst G
    Drug Metab Dispos; 2008 Jan; 36(1):87-94. PubMed ID: 17932223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brush-border-enzyme-mediated intestine-specific drug delivery. Amino acid prodrugs of 5-aminosalicylic acid.
    Pellicciari R; Garzon-Aburbeh A; Natalini B; Marinozzi M; Clerici C; Gentili G; Morelli A
    J Med Chem; 1993 Dec; 36(26):4201-7. PubMed ID: 8277502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of brush-border membrane peptidases along the intestine of rabbits and rats: implication for site-specific delivery of peptide drugs.
    Bai JP
    J Drug Target; 1993; 1(3):231-6. PubMed ID: 8069564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of transmucosal absorption of biologically active peptide drugs].
    Yamamoto A
    Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.